Deciphera Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. DCPH has around 2.1M shares in the U.S. ETF market. The largest ETF holder of DCPH is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 521.22K shares. Investors may also find of interest that the ETF with the largest allocation to DCPH stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 2.43%. On average, U.S. ETFs allocate 0.25% of DCPH to their portfolios.
Additionally, DCPH is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DCPH as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.